Original Research 


A novel score for diagnosis of liver fibrosis based on Th17 activity and sera fibrosis biomarkers

Soad Nady, Asmaa Ezz, Mohammad A. Mohey, Gamal Esmat, Wafaa Elakel, Mohammad T. Shata.

Abstract
Background: Fibrosis is a major cause of morbidity and mortality worldwide. Biopsy is an invasive procedure. For the evaluation of liver fibrosis, an alternative, noninvasive, new, easy, and available method is determined to assess hepatic fibrosis in Egyptian patients.
Methodology: We enrolled 143 patients with fibrosis and they were divided into two groups, severe fibrosis and mild fibrosis group. Th17 cells were stimulated in vitro with S. mansoni soluble egg antigen (SEA), then interleukin (IL)-17, IL-22, and interferon (IFN)-γ were assessed in the culture supernatant. Serum levels of alanine aminotransferase, aspartate aminotransferase, YKL-40, and hyaluronic acid (HA) were also assessed using enzyme-linked immunosorbent assay. Analysis of individual data was conducted to characterize the diagnostic accuracy of the three highly significant fibrosis biomarkers (HA, IL-22, and IFN-γ).
Results: A highly significant difference in IL-22, IFN-γ, and HA levels between mild and severe groups was observed. Linear combination of the three biomarkers was selected by the multivariate discriminate analysis as the best combination for construction of the fibrosis discrimination equation. Application of the equation on all patients correctly classified 28.7% with severe fibrosis and 71.3% with mild fibrosis at a discriminant cut-off score (0.297) with 87.18% sensitivity and 85.57% specificity.
Conclusion: A simple fibrosis score = [0.594 (numerical constant) + 0.007 HA (ng/ml) + 0.006 IL-22 (ng/ml) − 0.129 IFN-γ (pg/ml)] may be useful for discrimination of severe from mild fibrosis patients without the need of liver biopsy.

Key words: liver fibrosis, Th17 cells, sera fibrosis biomarkers


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Soad Nady
Articles by Asmaa Ezz
Articles by Mohammad A. Mohey
Articles by Gamal Esmat
Articles by Wafaa Elakel
Articles by Mohammad T. Shata
on Google
on Google Scholar
Article Statistics
 Viewed: 545
Downloaded: 80
Cited: 0

How to Cite this Article
Pubmed Style

Nady S, Ezz A, Mohey MA, Esmat G, Elakel W, Shata MT. A novel score for diagnosis of liver fibrosis based on Th17 activity and sera fibrosis biomarkers. IJMDC. 2017; 1(3): 99-106. doi:10.24911/IJMDC.2.1.5


Web Style

Nady S, Ezz A, Mohey MA, Esmat G, Elakel W, Shata MT. A novel score for diagnosis of liver fibrosis based on Th17 activity and sera fibrosis biomarkers. http://www.ijmdc.com/?mno=291229 [Access: June 19, 2018]. doi:10.24911/IJMDC.2.1.5


AMA (American Medical Association) Style

Nady S, Ezz A, Mohey MA, Esmat G, Elakel W, Shata MT. A novel score for diagnosis of liver fibrosis based on Th17 activity and sera fibrosis biomarkers. IJMDC. 2017; 1(3): 99-106. doi:10.24911/IJMDC.2.1.5



Vancouver/ICMJE Style

Nady S, Ezz A, Mohey MA, Esmat G, Elakel W, Shata MT. A novel score for diagnosis of liver fibrosis based on Th17 activity and sera fibrosis biomarkers. IJMDC. (2017), [cited June 19, 2018]; 1(3): 99-106. doi:10.24911/IJMDC.2.1.5



Harvard Style

Nady, S., Ezz, A., Mohey, M. A., Esmat, G., Elakel, W. & Shata, M. T. (2017) A novel score for diagnosis of liver fibrosis based on Th17 activity and sera fibrosis biomarkers. IJMDC, 1 (3), 99-106. doi:10.24911/IJMDC.2.1.5



Turabian Style

Nady, Soad, Asmaa Ezz, Mohammad A. Mohey, Gamal Esmat, Wafaa Elakel, and Mohammad T. Shata. 2017. A novel score for diagnosis of liver fibrosis based on Th17 activity and sera fibrosis biomarkers. International Journal of Medicine in Developing Countries, 1 (3), 99-106. doi:10.24911/IJMDC.2.1.5



Chicago Style

Nady, Soad, Asmaa Ezz, Mohammad A. Mohey, Gamal Esmat, Wafaa Elakel, and Mohammad T. Shata. "A novel score for diagnosis of liver fibrosis based on Th17 activity and sera fibrosis biomarkers." International Journal of Medicine in Developing Countries 1 (2017), 99-106. doi:10.24911/IJMDC.2.1.5



MLA (The Modern Language Association) Style

Nady, Soad, Asmaa Ezz, Mohammad A. Mohey, Gamal Esmat, Wafaa Elakel, and Mohammad T. Shata. "A novel score for diagnosis of liver fibrosis based on Th17 activity and sera fibrosis biomarkers." International Journal of Medicine in Developing Countries 1.3 (2017), 99-106. Print. doi:10.24911/IJMDC.2.1.5



APA (American Psychological Association) Style

Nady, S., Ezz, A., Mohey, M. A., Esmat, G., Elakel, W. & Shata, M. T. (2017) A novel score for diagnosis of liver fibrosis based on Th17 activity and sera fibrosis biomarkers. International Journal of Medicine in Developing Countries, 1 (3), 99-106. doi:10.24911/IJMDC.2.1.5




Current Issue : 2018, Vol: 2, Issue: 2
E-ISSN : 1658-7820
ISSUES : 3 per year
PUBLISHER : Published by Discover Publishing Ltd (UK & Ireland)

Benefits of publishing in International Journal of Medicine in Developing Countries

  • Online submission
  • Wider visibility through open access
  • Higher impact
  • Prompt review

Abstracting and Indexing Information

CrossRef

ScopeMed

Scilit

Indexing in progress for

PubMed

Index Medicus

Index Copernicus

 


Approved by: Ministry of Communication and Information Technology, Saudi Arabia المملكة العربية السعودية - وزارة الاتصالات وتقنية المعلومات